#8528. Repetitive use of LEvosimendan in Ambulatory Heart Failure patients (LEIA-HF) - The rationale and study design

July 2026publication date
Proposal available till 07-09-2025
4 total number of authors per manuscript4500 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Medicine (all);
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeSold outSold out
1350 $1200 $1050 $900 $
Contract №8528.1 Contract №8528.2 №8528.3№8528.4
1 place - free (for sale)
2 place - free (for sale)
3 place - sold out (contract 8421)
4 place - sold out (contract 7647)

Abstract:
The current study aims to determine the efficacy and safety of repeated levosimendan used to treat heart failure with reduced ejection fraction. The paper presents the drug side effects, comprehensive clinical assessment, and appropriate definition of endpoints.
Keywords:
Advanced heart failure; Hospitalization due to heart failure; Levosimendan; Outpatients; Repetitive infusions

Contacts :
0